The value of stocks listed in the United Arab Emirates has surpassed $1 trillion for the first time. This occurred as a result of a growth in local listings and a rise in companies associated with Abu Dhabi royals, which make up over one-third of the total valuation. As a result, the UAE market as […]
UAE-listed stocks top $1 trillion in value for the first time: Know More Here Read More »
According to persons familiar with the situation, billionaire Gautam Adani’s renewable energy division intends to raise at least $2 billion in primarily fresh debt next year to take advantage of creditors’ renewed faith in its ambitious expansion plans. According to persons who asked not to be named because the discussions are confidential, Ahmedabad-based Adani Green
Adani Green Energy plans $2-b fundraise via International bonds, loans Read More »
Nithin Kamath, chief executive officer of Zerodha, stated that the development possibilities for the Bengaluru-based company in the upcoming years will be impacted by the stock market’s expected plateau following the exuberance of the previous four years, which resulted in record participation from individual investors. “Zerodha’s performance would be highly correlated with the performance of
Early on Monday, Asian equities fell as traders tempered their expectations of interest rate reduction from the Federal Reserve in response to further evidence of the US economy’s resiliency. Australian and Japanese stocks dropped. Samsung Electronics Co.’s surge on the announcement of its stock repurchase plan was the catalyst for South Korea’s benchmark to defy
Asian stocks weaken as Fed policy doubts simmer: Know More Here Read More »
The pricing range for the Enviro Infra Engineers Limited initial public offering (IPO) has been set between ₹140 and ₹148 for each equity share with a face value of ₹10. The subscription period for the Enviro Infra Engineers initial public offering (IPO) is set for Friday, November 22, and it will end on Tuesday, November
Enviro Infra Engineers IPO Date, Price, & More Read More »
A decline in the dollar and indications of economic stabilization in China helped Asian stocks rise. Australia’s and Hong Kong’s stocks rose after statistics revealed that China’s retail sales growth was the largest in eight months. Because of the yen’s depreciation, Japanese benchmarks increased by almost 0.8%. US contracts declined. A five-day increase that was
Asian Stocks Gain on China Recovery, Weaker Dollar: Markets Wrap Read More »
Muted sales growth and a drop in profits and margins have been the hallmarks of the second quarter of FY25’s disappointing corporate earnings. Notwithstanding the respectable performance of the Banking, Financial Services, and Insurance (BFSI) industry, non-financial businesses nonetheless confront formidable obstacles. 45% of the 227 companies in the 275-stock JM Financial coverage area have
Q2 Results Review: 66% companies see EPS cut, small and midcaps hit hard Read More »
As a weaker yen helped manufacturers and financial sectors rise after increasing their yearly profit projections, Japan’s Nikkei share average increased on Friday. The Nikkei is expected to lose 2.4% for the week, despite being up 0.8% at 38,842.13 during the lunch break. Although the overall Topix has increased by 0.86% to 2,724.35, it is
Japan’s Nikkei rises as auto, bank shares gain: All You Need To Know Read More »
In November, the Nifty Pharma index had a 4% drop. Even though it started on a high base, the growth of the Indian pharmaceutical industry in October was not particularly encouraging, and the selling pressure in the domestic markets is what caused this fall. According to reports, the growth of the pharmaceutical market in October
JB Pharma, Sun, Torrent ,Lupin, Abbott lead pharma market growth : Know More Here Read More »
Bharat Serums and Vaccines Limited (BSV), a fully-owned subsidiary of Mankind Pharma Limited, has pledged 39.68 per cent of its equity stake to secure non-convertible debentures (NCDs) worth ₹5,000 crores. As the common security trustee for these NCDs, Catalyst Trusteeship Limited was designated by SEBI’s Listing Obligations and Disclosure Requirements Regulations, 2015. The share price
Mankind Pharma pledges 39.68% stake in Bharat Serums to secure ₹5,000 crore NCDs Read More »
